Moyamoya DiseaseSymptoms, Doctors, Treatments, Advances & More
Learn About Moyamoya Disease
Condition 101 content is not available at this time, but we are continually updating the site. Please check back.
However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.
Northwell Health Neurosurgery & Spine
Amir Dehdashti is a Neurosurgery provider practicing medicine in Great Neck, New York. Dr. Dehdashti is rated as an Elite provider by MediFind in the treatment of Moyamoya Disease. He is also highly rated in 29 other conditions, according to our data. His clinical expertise encompasses Moyamoya Disease, Pituitary Tumor, Cerebral Arteriovenous Malformation, Cerebral Artery Bypass Surgery, and Extracranial-Intracranial Bypass Surgery.
Swedish Cerebrovascular Center
Dr. Patel is a neurosurgeon at the Swedish Neuroscience Institute. His philosophy of care is to provide comprehensive care and superior service in order to help and change the lives of his patients for the better. Dr. Patel is rated as an Advanced provider by MediFind in the treatment of Moyamoya Disease. He is also highly rated in 23 other conditions, according to our data. His clinical expertise encompasses Brain Aneurysm, Stroke, Subdural Hematoma, Cerebral Artery Bypass Surgery, and Extracranial-Intracranial Bypass Surgery. Dr. Patel is board certified in American Board Of Neurological Surgery. Dr. Patel is currently accepting new patients.
Office
Gary Steinberg is a Neurosurgery provider practicing medicine in Palo Alto, California. Dr. Steinberg is rated as an Elite provider by MediFind in the treatment of Moyamoya Disease. He is also highly rated in 38 other conditions, according to our data. His clinical expertise encompasses Moyamoya Disease, Stroke, Arteriovenous Malformation, Extracranial-Intracranial Bypass Surgery, and Cerebral Artery Bypass Surgery.
Summary: This single-center, prospective, family-based observational cohort study aims to investigate susceptibility to moyamoya disease (MMD) and to develop strategies for early screening in individuals at increased familial risk. The study will enroll three groups: patients with MMD, their first-degree relatives, and healthy controls without a family history of MMD. The rationale for this study is that M...
Summary: The goal of this clinical trial is to obtain initial feedback on the implementation of the STRATIF-AI platform and digital twin in the secondary prevention phase in patients with stroke, Moyamoya disease and Cerebral amyloid angiopathy, including adults of both sexes. The main questions it aims to answer is: how is the patients' experience regarding the use of the STRATIF-AI platform? Researchers ...